Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects
Abstract Background Functional recovery is an important treatment goal in major depressive disorder (MDD). This study assessed the real-world effectiveness of vortioxetine in patients with MDD, with particular focus on functioning; dose–response was also assessed. Methods This was a non-intervention...
Main Authors: | Eugenia Papalexi, Andreas Galanopoulos, Dimitrios Kontis, Maria Markopoulou, Georgia Balta, Evaggelos Karavelas, Panagiotis Panagiotidis, Themistoklis Vlachos, Anders Ettrup |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-022-04109-5 |
Similar Items
-
The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
by: E. Papalexi, et al.
Published: (2021-04-01) -
Improvements in mood symptoms, cognitive symptoms and functioning in outpatients with mdd in greece treated with vortioxetine: A patient-rated evaluation
by: A. Galanopoulos, et al.
Published: (2021-04-01) -
Evaluating an EEG-based tool for assessing acute clinical and cognitive changes in adult outpatients with MDD treated with open-label, flexible-dose vortioxetine: A pilot study
by: John Zajecka, et al.
Published: (2024-04-01) -
Vortioxetine usage in an elderly patient with major depressive disorder and accompanied by multiple physical conditions: A case report
by: Xiaoman Wang, et al.
Published: (2023-12-01) -
Hypomanic switch during vortioxetine treatment: a case report
by: Efruz Pirdoğan Aydın, et al.
Published: (2019-01-01)